Trending Now
Abeona Therapeutics Inc. (NASDAQ:ABEO) Says It IS Resuming Patient Enrollment in...
Abeona Therapeutics Inc. (NASDAQ:ABEO) is about to begin patient enrollment in its pivotal Phase 3 VITAL study of EB-101. The enrollment is resuming after...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Apple Inc (NASDAQ:AAPL) is susceptible to trade war
Everyone knows the market is overbought up here. But let me throw some coal on the fire by giving you some perspective...
MAKE IT MODERN
LATEST REVIEWS
Recession-free stocks to place on top of radar (DG,TGT,DLTR,GOOG,BIG)
Only time will tell if we are heading into a recession as the central bank’s aggressive rate hikes start to slow the...
MAKE IT MODERN
PERFORMANCE TRAINING
IBM Watson Health Selects iBio Inc. (NYSEAMERICAN:IBIO) To Use Its ICD Solution For Development...
iBio Inc. (NYSEAMERICAN:IBIO) has announced that it has been selected by IBM Watson Health to use the IBM Clinical Development solution for 18 months.
ICD...
New Small-Cap Opportunities Emerge in the Multi-Billion-Dollar Carbon Capture Space (FLR, VKIN, CLNE, NEE,...
The world is scrambling to manage the process of transitioning away from fossil fuels over the coming decade. We know that’s where...
Clovis Oncology Inc. (NASDAQ:CLVS) Releases Q4 and FY2020 Financial Results And Offers Clinical Development...
Clovis Oncology Inc. (NASDAQ:CLVS) has announced its Q4 2020 and full year ended December 31 results and offered an update on its clinical development...
Genocea Biosciences (GNCA) could be a corona virus stock waiting to explode
Genocea Biosciences (GNCA) is a small cap company with a mission to conquer cancer by developing personalized cancer immunotherapies in multiple tumor...
Royalty Pharma Plc (NASDAQ:RPRX) Shares Surge Over 60% Following Successful IPO
Royalty Pharma Plc (NASDAQ:RPRX) shares surged 59% after it made its trading debut following an upsized IPO, which braised $2.18 billion with top of...
MAKE IT MODERN
